Connection
Joseph Saseen to Diabetes Mellitus, Type 2
This is a "connection" page, showing publications Joseph Saseen has written about Diabetes Mellitus, Type 2.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.688 |
|
|
|
-
Thompson AM, Linnebur SA, Vande Griend JP, Saseen JJ. Glycemic targets and medication limitations for type 2 diabetes mellitus in the older adult. Consult Pharm. 2014 Feb; 29(2):110-23.
Score: 0.161
-
Thompson A, Vande Griend JP, Linnebur SA, Saseen JJ. Evaluation of type 2 diabetes mellitus medication management and control in older adults. Consult Pharm. 2013 May; 28(5):296-306.
Score: 0.153
-
Anderson SL, Trujillo JM, McDermott M, Saseen JJ. Determining predictors of response to exenatide in type 2 diabetes. J Am Pharm Assoc (2003). 2012 Jul-Aug; 52(4):466-71.
Score: 0.144
-
Sferra L, Kelsberg G, Dodson S, Saseen J. Clinical inquiries. Do ACE inhibitors prevent nephropathy in type 2 diabetes without proteinuria? J Fam Pract. 2004 Jan; 53(1):68-9.
Score: 0.080
-
Trudeau BM, Allen LA, Billups SJ, Saseen JJ, Pearson SM. Evaluation of Loop Diuretic Dosing Following Sodium-Glucose Cotransporter 2 Inhibitor Initiation in Patients With Heart Failure. J Pharm Pract. 2023 Dec; 36(6):1330-1335.
Score: 0.072
-
Uzal NE, Chavez B, Kosirog ER, Billups SJ, Saseen JJ. Monitoring of Recommended Metabolic Laboratory Parameters Among Medicaid Recipients on Second-Generation Antipsychotics in Federally Qualified Health Centers. Ann Pharmacother. 2018 02; 52(2):160-165.
Score: 0.052
-
Marrs JC, Saseen JJ. Which patients are candidates for dipeptidyl peptidase IV inhibitors? Am J Health Syst Pharm. 2007 Jun; 64(12):1261.
Score: 0.025